Pulmonary Function Testing (PFT) is a key tool in the diagnostic arsenal of respiratory medicine, providing vital information about lung function. Yet, the complexity of PFT interpretation often poses a challenge for healthcare professionals.
The core parameters of PFTs include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and the FEV1/FVC ratio. FVC represents the total amount of air exhaled forcefully after maximal inspiration. FEV1 is the volume exhaled during the first second of the FVC maneuver. The FEV1/FVC ratio is a useful index for detecting airway obstruction.
Interpretation involves assessing these parameters against predicted normal values. A reduced FEV1/FVC ratio (<70%) indicates obstructive lung disease. If FEV1 and FVC are proportionately reduced with a normal FEV1/FVC ratio, it suggests a restrictive pattern. Mixed defects show both obstructive and restrictive features.
Assessing bronchodilator response is crucial in diagnosing conditions like asthma. A significant increase in FEV1 or FVC post-bronchodilator administration indicates reversible airway obstruction, a hallmark of asthma.
DLCO measures the lung's ability to transfer gas from inhaled air to the red blood cells. Reduced DLCO may indicate interstitial lung disease, pulmonary vascular disease, or emphysema.
Decoding PFT results is a nuanced process, requiring a solid understanding of respiratory physiology and diseases. By understanding the key parameters and their implications, healthcare professionals can effectively use PFTs to diagnose, monitor, and manage respiratory conditions. Continued education and practice are essential to enhance proficiency in PFT interpretation.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation